Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): Recent developments

被引：16
|
作者：
Simon, GR
Bunn, PA
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Program, Tampa, FL 33612 USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
来源：
CANCER INVESTIGATION | 2003年 / 21卷 / 01期
关键词：
non-small cell lung cancer; chemotherapy; radiaion therapy; cisplatin; carboplatin; paclitaxel; docetaxel; gemcitabine; vinorelbine;
D O I：
10.1081/CNV-120005919
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Taxanes, paclitaxel. and docetaxel have become the cornerstone of both first-line and second-line chemotherapy for advanced non-small cell lung cancer (NSCLC). Recently, several pivotal phase III randomized trials have been published. These studies and phase II trials will be discussed. Additionally, studies utilizing a taxane and radiation therapy for resectable and locally advanced NSCLC will be outlined. The article will end with a discussion on newer strategies being currently explored to improve survival in advanced NSCLC.
引用
收藏
页码：87 / 104
页数：18
相关论文
共 50 条
  • [1] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [2] The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    ONCOLOGIST, 2009, 14 (04) : 412 - 424
  • [3] Treatment Paradigms for Advanced Stage Non-small Cell Lung Cancer in the Era of Multiple Lines of Therapy
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 243 - 250
  • [4] Surgical treatment of stage IV non-small cell lung cancer
    Kawano, Daigo
    Takeo, Sadanori
    Katsura, Masakazu
    Tsukamoto, Shuichi
    Masuyama, Eri
    Nakaji, Yu
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (02) : 167 - 170
  • [5] Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer
    Rigas, JR
    Lara, PN
    LUNG CANCER, 2005, 50 : S17 - S24
  • [6] Randomized Phase II Study of Paclitaxel and Carboplatin or Vinorelbine in Advanced Non-small Cell Lung Cancer
    Jahnke, Kristoph
    Keilholz, Ulrich
    Lueftner, Diana
    Thiel, Eckhard
    Schmittel, Alexander
    ANTICANCER RESEARCH, 2011, 31 (01) : 317 - 323
  • [7] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
    Camps, C.
    Felip, E.
    Garcia-Campelo, R.
    Trigo, J. M.
    Garrido, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12) : 977 - 984
  • [8] STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): PATTERNS OF TREATMENT IN BRITISH COLUMBIA, CANADA
    Vinod, Shalini K.
    Wai, Elaine
    Alexander, Cheryl
    Christie, Jennifer
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S625 - S625
  • [9] The current status of docetaxel for advanced non-small cell lung cancer
    Green, MR
    ANTI-CANCER DRUGS, 2001, 12 : S11 - S16
  • [10] Chemotherapy in elderly patients with advanced non-small cell lung cancer
    Quoix, Elisabeth
    Westeel, Virginie
    Zalcman, Gerard
    Milleron, Bernard
    LUNG CANCER, 2011, 74 (03) : 364 - 368
12345